Aberdeen Wealth Management’s CVS Health CVS Stock Holding History

Aberdeen Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Buy	+1,004	New	+$89.6K	0.05%	173
2024 Q2	–	Sell	-2,874	Closed	-$229K	–	170
2024 Q1	$229K	Buy	2,874 +3	+0.1%	+$229	0.13%	142
2023 Q4	$227K	Sell	2,871 -73	-2%	-$5.2K	0.16%	137
2023 Q3	$206K	Buy	2,944 +2	+0.1%	+$142	0.15%	141
2023 Q2	$203K	Sell	2,942 -228	-7%	-$16.2K	0.15%	139
2023 Q1	$236K	Buy	3,170 +381	+14%	+$31.9K	0.18%	131
2022 Q4	$260K	Buy	2,789 +166	+6%	+$16K	0.2%	126
2022 Q3	$250K	Buy	2,623 +1	+0%	+$99	0.22%	117
2022 Q2	$243K	Buy	2,622 +2	+0.1%	+$195	0.19%	126
2022 Q1	$265K	Buy	2,620 +196	+8%	+$20.6K	0.18%	129
2021 Q4	$250K	Buy	2,424 +1	+0%	+$92	0.16%	128
2021 Q3	$206K	Buy	+2,423	New	+$203K	0.2%	121

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Aberdeen Wealth Management's CVS Position: Q2 2026 in Review

Aberdeen Wealth Management opened a new position in CVS Health (CVS) in Q2 2026: 1,004 shares worth $104K. The stake represents 0.05% of the portfolio and ranks #173 among its holdings. This is a return to the name: Aberdeen Wealth Management previously reported a position in CVS as recently as Q1 2024.

Aberdeen Wealth Management first reported a position in CVS in Q3 2021 and has held it in 12 quarters since. The position peaked at $265K in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Aberdeen Wealth Management held 1,004 shares of CVS Health worth $104K as of Q2 2026.
CVS Health was a new Aberdeen Wealth Management position in Q2 2026.
CVS Health made up 0.05% of Aberdeen Wealth Management's portfolio in Q2 2026, its #173 holding.
Aberdeen Wealth Management first reported a position in CVS Health in Q3 2021 and has held it in 12 quarters since.
Aberdeen Wealth Management's CVS Health position peaked at $265K in Q1 2022.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.